Topische Therapie einer persistierenden kutanen Leishmaniase mit Paromomycin

Flaig, Michael J.; Rupec, Janine; Ruzicka, Thomas; Rupec, Rudolf A.

doi:10.1007/s00105-007-1297-x

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Systemische Nebenwirkungen treten hierbei selten auf [2,12], jedoch können die intrafokalen Injektionen schmerzhaft sein. Alternativ [7] oder aufgrund der beschriebenen Antimonresistenzen [13] zusätzlich ist eine Lokaltherapie mit Paromomycin 15 % zweimal täglich möglich [9,10]. Nach mehrwöchiger Anwendung liegt die Heilungsrate bei ca.…”

unclassified

Kutane Leishmaniase der Alten Welt nach Spanienaufenthalt

Feise¹,

Müllerschön²,

Steigleder³

et al. 2010

Akt Dermatol

View full text Add to dashboard Cite

unclassified

Kutane Leishmaniase der Alten Welt nach Spanienaufenthalt

Feise¹,

Müllerschön²,

Steigleder³

et al. 2010

Akt Dermatol

View full text Add to dashboard Cite

“…S ir , Leishmaniasis is an infectious disease with increasing incidence and prevalence in northern Europe, mostly due to widespread travelling of the population 1 . The clinical appearance of cutaneous leishmaniasis is most often associated with a papule or nodule, sometimes with ulceration.…”

mentioning

confidence: 99%

Cutaneous pseudolymphoma in association with Leishmania donovani

Flaig¹,

Rupec²

2007

Br J Dermatol

Self Cite

View full text Add to dashboard Cite

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review

Rocha¹,

Pereira

Maia³

2022

Pathogens

View full text Add to dashboard Cite

Leishmaniases are human and animal parasitic diseases transmitted by phlebotomine sand flies. Globalization is an important driver of the burden and in the current dynamics of these diseases. A systematic review of articles published between 2000 and 2021 was conducted using the PubMed search engine to identify the epidemiology and clinical management of imported human leishmaniases as a fundamental step to better manage individual cases and traveler and migrant health from a global perspective. A total of 275 articles were selected, representing 10,341 human imported cases. Identified drivers of changing patterns in epidemiology include conflict and war, as well as host factors, such as immunosuppression, natural and iatrogenic. Leishmania species diversity associated with different clinical presentations implies diagnostic and treatment strategies often complex to select and apply, especially in non-endemic settings. Thus, diagnostic and management algorithms for medical clinical decision support are proposed. Increased surveillance of non-endemic cases, whether in vulnerable populations such as refugees/migrants and immunocompromised individuals or travelers, could improve individual health and mitigate the public health risk of introducing Leishmania species into new areas.

show abstract

Topische Therapie einer persistierenden kutanen Leishmaniase mit Paromomycin

Cited by 3 publications

References 16 publications

Kutane Leishmaniase der Alten Welt nach Spanienaufenthalt

Kutane Leishmaniase der Alten Welt nach Spanienaufenthalt

Cutaneous pseudolymphoma in association with Leishmania donovani

Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021—A Comprehensive Review

Contact Info

Product

Resources

About